Categories: News

Ario Khoshbin Announces the Launch of Phiusion Labs, Advancing Next-Generation Wellness and Regenerative Technologies

RICHMOND HILL, ON, Oct. 2, 2025 /PRNewswire/ – Entrepreneur and innovator Ario Khoshbin today announced the launch of Phiusion Labs, a new company dedicated to advancing wellness, regenerative medicine, and next-generation technologies that support skin health. With its new headquarters planned at 29 East Wilmot in Richmond Hill, Ontario, Phiusion Labs is designed to become a hub for scientific research and product innovation.

The company is preparing to begin the construction of a state-of-the-art laboratory, clean rooms, and a dedicated training facility, scheduled for completion in Q2 2026. Phiusion Labs also plans to build capacity for the development and production of proprietary raw materials, ensuring complete quality control and enabling innovation at every stage.

“Phiusion Labs is about reimagining what’s possible,” said Ario Khoshbin, Founder of Phiusion Labs. “People today are seeking healthier, more natural approaches to aging and wellness. They want solutions that support strong, radiant skin and overall confidence, rather than approaches that can leave results feeling unnatural. At Phiusion Labs, we are focused on developing next-generation actives, differentiated ingredients, and advanced technologies to meet this demand in new and innovative ways.”

About Ario Khoshbin

Ario Khoshbin is the Founder of Phiusion Labs, a company pioneering next-generation wellness and regenerative technologies. An immigrant from Iran whose family fled persecution during the 1979 revolution, Ario has built a life defined by resilience, entrepreneurship, and passion.

He is best known as the Founder and former CEO of Prollenium Medical Technologies, which he established in 2001 and grew into a recognized company in the aesthetics industry. Building on that experience, Ario has launched Phiusion Labs to push the boundaries of science, design, and innovation in the broader fields of wellness and regenerative medicine.

About Phiusion Labs

Phiusion Labs is a forward-thinking company dedicated to advancing wellness, regenerative medicine, and skin health technologies. By focusing on next-generation actives, differentiated ingredients, proprietary raw material development, and advanced rejuvenation platforms, Phiusion Labs is building a vertically integrated model that redefines standards and delivers breakthrough solutions for the future. The company is headquartered in Richmond Hill, Ontario, with a new laboratory, clean rooms, and training facility planned at 29 East Wilmot, scheduled for completion in Q2 2026.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ario-khoshbin-announces-the-launch-of-phiusion-labs-advancing-next-generation-wellness-and-regenerative-technologies-302573304.html

SOURCE Ario Khoshbin

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

15 hours ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

20 hours ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

21 hours ago

University of Phoenix and LinkedIn to host webinar on AI in nursing with skills and strategies for a new era of healthcare

January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…

21 hours ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

21 hours ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

1 day ago